MZMadeleine Zetterberg

Madeleine Zetterberg

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Madeleine Zetterberg has a total of 204 co-authors. Here are the top co-authors by number of shared publications:

  • Anders Behndig

    EyeNet Sweden, Blekinge Hospital, Karlskrona, Sweden; Department of Clinical Sciences/Ophthalmology, Umeå University, Umeå, Sweden

    6 shared publications
  • Henrik Zetterberg

    B Department of Psychiatry and Neurochemistry , Institute of Neuroscience and Physiology, The Sahlgrenska Academy at University of Gothenburg , Mölndal , Sweden

    6 shared publications
  • Ingela Nilsson

    Capio Medocular AB Malmö Sweden

    6 shared publications
  • Dragana Škiljić

    Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden

    5 shared publications
  • Erkki Juronen

    C Department of Human Biology and Genetics , Institute of General and Molecular Pathology, University of Tartu , Tartu , Estonia , and

    5 shared publications
  • Gunnar Tasa

    C Department of Human Biology and Genetics , Institute of General and Molecular Pathology, University of Tartu , Tartu , Estonia , and

    5 shared publications

Latest Publications

  • Open Access

    Central retinal artery occlusion following transcatheter aortic valve implantation (TAVI) for aortic stenosis: a case report

    by Pablo Ballester Dolz, Kemal Mutibayraktaroglu, Yuri Belitsky, Philipp Schwember, Madeleine Zetterberg

    Background: Transcatheter aortic valve implantation is the standard treatment for high-risk elderly patients suffering from symptomatic severe aortic stenosis. While this procedure is significantly less invasive compared to traditional methods, there are concerns regarding the potential risk of cerebrovascular accidents and ocular complications. We report a case of monocular central retinal artery occlusion that occurred following transcatheter aortic valve implantation due to aortic stenosis. The occurrence of central retinal artery occlusion post-transcatheter aortic valve implantation has not previously been reported. Case presentation: A 78-year-old male presented with a sudden, painless loss of vision in the left eye immediately after undergoing transcatheter aortic valve implantation. Fundus examination revealed moderate optic disc edema, mild venous tortuosity and diffuse retinal pallor at the posterior pole, most marked in the perimacular region and extending along the major vascular arcades into the mid-peripheral retina, with a cherry-red spot at the fovea. Optical coherence tomography indicated signs of retinal ischemia. The patient was referred to the emergency department for further assessment. Conclusions: Although there is evidence of embolization occurring after TAVI, this is the first case of central retinal artery occlusion that has been reported. Our findings underscore the need for thorough pre-TAVI counseling, increased neurologist awareness of this complication, and prompt ophthalmologic evaluation in cases of sudden monocular visual loss.

  • Open Access

    Real‐world outcomes of aflibercept 8 mg in patients previously treated for neovascular age‐related macular degeneration

    by Imadeddin Abu Ishkheidem, Esra Inci, Martin Breimer, Sofia Töyrä Silfverswärd, Madeleine Zetterberg, Marita Andersson Grönlund

    Purpose: To evaluate visual, anatomical and safety outcomes of aflibercept 8 mg in previously treated patients with neovascular age‐related macular degeneration (nAMD). Methods: This retrospective study included nAMD patients switched to aflibercept 8 mg from prior anti‐VEGF therapies at Sahlgrenska University Hospital between February 2024 and February 2025. Data on best‐corrected visual acuity (BCVA), central retinal thickness (CRT), pigment epithelial detachment (PED) height, fluid status, treatment intervals, time to fluid recurrence and adverse events were collected. Results: 181 eyes (167 patients; mean age 80.4 ± 8.5 years; 67.7% female) were included, with a median follow‐up of 12.9 weeks (range 4.1–48.1). A total of 415 injections were administered (mean 2.1 ± 1.5 per eye). BCVA remained stable (baseline 0.46 ± 0.31 logMAR; post‐treatment 0.47 ± 0.37 logMAR; p = 0.18). CRT decreased significantly (−19.5 ± 47.2 μm; p < 0.001), as did PED height (−37.4 ± 68.4 μm; p < 0.001). Intraretinal fluid prevalence decreased from 34.3% to 19.3% ( p < 0.001) and subretinal fluid from 53.0% to 33.7% ( p < 0.001). The median maximal dry interval achieved was nine weeks, and analysis of interval extension showed a statistically significant mean increase of 1.27 ± 4.24 weeks overall ( p = 0.0009), particularly in eyes dry at baseline. The median time to fluid recurrence among those with reactivation was ten weeks. Higher baseline CRT predicted greater CRT reduction (−44.1 μm per 100 μm increase; p < 0.001) but shorter dry intervals. Safety was favourable, with one case (0.6% per eye; 0.2% per injection) of mild anterior uveitis and no cases of intraocular pressure elevation. Conclusions: Switching to aflibercept 8 mg led to stable vision, significant anatomical improvements, extended treatment intervals and a favourable short‐term safety profile. Longer follow‐up is warranted.


  • Open Access

    Predictors of Selective Laser Trabeculoplasty Efficacy

    by Tobias Dahlgren, Marcelo Ayala, Madeleine Zetterberg


  • Open Access

    Secondary ocular hypertension as an adverse effect of treatment with intravitreal dexamethasone implant: A retrospective Swedish cohort study

    by Imadeddin Abu Ishkheidem, Martin Breimer, Saba Kamal, Madeleine Zetterberg, Abbas Al‐Hawasi, Marita Andersson Grönlund

    Purpose: To evaluate the incidence and risk factors for secondary ocular hypertension (SOHT) following intravitreal dexamethasone implants (Ozurdex®) in patients with diabetic macular oedema (DME) and macular oedema secondary to retinal vein occlusion (RVO) in a Swedish cohort.Methods: This retrospective study included 309 eyes from 249 patients treated with Ozurdex® at Sahlgrenska University Hospital, Mölndal, Sweden, from 1 January 2016 to 31 December 2023. Electronic medical records were reviewed for data including patient demographics, number of injections, incidence of and treatment modalities for SOHT and rate of Ozurdex® discontinuation.Results: Of the 309 eyes, 217 (70.2%) were in the DME group and 92 (29.8%) in the RVO group. Overall, 117 eyes (37.9%) developed SOHT (intraocular pressure (IOP) ≥25 mmHg or a rise of ≥10 mmHg from baseline); this included 77 of 217 DME eyes (35.5%) and 40 of 92 RVO eyes (43.5%). Men were more than twice as likely as women to develop SOHT (adjusted odds ratio [aOR]: 2.53, p < 0.001). Each unit increase in baseline IOP was associated with an 8% increase in the odds of SOHT (aOR: 1.08 p = 0.025). Of all eyes, 30.5% received IOP‐lowering treatment, primarily prostaglandins. None required invasive surgery.Conclusion: Our finding that 30.5% of eyes received IOP‐lowering treatment confirms that SOHT is a prevalent complication following intravitreal dexamethasone implants. Male gender and higher baseline IOP were key indicators for developing SOHT after Ozurdex® treatment, emphasizing the need for vigilant monitoring. Most cases were managed with IOP‐lowering eye drops, indicating that while common, SOHT is typically manageable without invasive interventions.


  • Open Access

    Self‐perceived and measured visual function, the impact of eye‐disease, wellbeing, social determinants, and personality traits in Swedish 70‐year‐olds–results from the Gothenburg H70 Study

    by Lena Havstam Johansson, Madeleine Zetterberg, Hanna Falk Erhag

    Purpose: To explore the potential correlation between subjective and measured visual function, as well as to analyse the influence of eye disease, socioeconomic factors and emotional dimensions.Methods: Semi‐structured interviews, physical examinations and functional tests (n = 1203). Demographics covered sex, marital status, education, household economy, smoking and alcohol. Participants (born in 1944) rated their visual function (n = 533); those misjudging (n = 48) were studied. Group A (n = 18) had low presenting visual acuity (PVA) but reported good vision; Group B (n = 30) had normal PVA but reported low vision. Control group (n = 485) matched subjective and measured visual function. Ophthalmic examination tested visual acuity (VA), visual field and contrast sensitivity (CS). Psychometric tests: NEO‐FFI, sense of coherence (SOC) and Montgomery–Åsberg Depression Rating Scale (MADRS). Statistical tests: chi‐square, t‐tests, Mann–Whitney U test and logistic regression.Results: Of the population, 91% made correct assumptions about their vision. The 9% who made incorrect assumptions about their vision ability (combining groups A + B) were more likely to live alone (p = 0.02) and had lower household incomes compared to the control group (p = 0.04). Additionally, the exhibited significantly lower PVA and BCVA, a higher prevalence of visual field defects (p = 0.02) and lower CS, mean 1.63 (p = 0.005). Group A (3.4%) were women (p = 0.002) with the personality of extraversion, mean 40.0 (p = 0.01). Group B (5.6%) had more self‐reported eye diseases (p = 0.01), lower CS (p = 0.01), lower educational level (p = 0.03) and border significantly lower SOC (p = 0.06).Conclusions: The perception of visual function is shaped by awareness of an eye disease but is additionally influenced by sex, socioeconomic factors and emotional parameters.


  • Open Access

    The more smoking the more cataract: A study on smoking, snus use and cataract in a Swedish population

    by Moa Nordström, Madeleine Zetterberg, Kjell Torén, Linus Schiöler, Mathias Holm

    Purpose: To examine the prevalence of self‐reported cataract and cataract surgery, and the incidence of cataract surgery, in relation to smoking and use of the moist smokeless tobacco product snus.Methods: In 2014/2015, individuals born in 1951 (n = 18 055) in the Västra Götaland County, Sweden, were invited to participate. Of these, 9743 (54%) accepted participation and 9316 (52%) remained after exclusion criteria were applied. Participants answered a questionnaire with items about eye conditions, smoking, snus, gender, education, asthma, chronic obstructive pulmonary disease, corticosteroid use, diabetes mellitus, weight and height. Prevalence ratios (PRs) for self‐reported cataract and cataract surgery were calculated. The incidence of cataract surgery was assessed, and hazard ratios (HRs) were presented.Results: Having ever smoked was associated with a higher prevalence ratio of self‐reported cataract (PR 1.19, 95% confidence interval [CI] 1.04–1.35) and cataract surgery (PR 1.27, 95% CI 1.06–1.53), compared to those who had never been daily smokers. Currently, a smoker was associated with a higher HR of cataract surgery (HR 1.34, 95% CI 1.04–1.74), as well as having been a former smoker (HR 1.27, 95% CI 1.03–1.56). Total years of smoking were associated with an increased risk for cataract surgery (HR 1.05, 95% CI 1.02–1.08 for 5 years of smoking). Snus use was not associated with an increased prevalence of cataract or incidence of cataract surgery, except among women who were current snus users (HR for cataract surgery 2.04, 95% CI 1.16–3.60 n = 108).Conclusion: Smoking is associated with a higher prevalence of cataracts, and a higher incidence of cataract surgery, indicating a dose–response relationship. However, there was no firm association between snus use and cataract.


  • Open Access

    Phacoemulsification practices: A comprehensive analysis of the surgical landscape in Sweden 2021–2022

    by Johan Ursberg, Madeleine Zetterberg, Andreas Viberg

    Purpose: This cross‐sectional survey study aimed to explore the phacoemulsification techniques among Swedish cataract surgeons, and investigate the association between technique preferences and surgical outcomes, particularly posterior capsular rupture (PCR).Methods: A survey questionnaire was responded by 170 cataract surgeons and data from 192 494 cases, linked to the surgeons, were analysed from the Swedish National Cataract Registry (SNCR) for 2021–2022. Surgeons' demographic characteristics, surgical techniques and complications were assessed. Associations between surgical technique preferences and outcomes were analysed with binary logistic regression.Results: The chopping technique (stop and chop or direct chop) was favoured by 64.6% of surgeons, followed by divide and conquer (32.4%), and tilt and tumble (7.6%). Surgeons' annual caseloads varied widely (range 11–2687). No significant correlation was found between technique preference and PCR rates, which was consistently 0.5%–0.6% in all groups, except for a trend suggesting reduced risk with tilt and tumble. Mentoring activity (35.0%) and public surgical setting (40.3%) was highest in the direct chop group. Notably, 75% of the surgeries were performed by surgeons with more than 10 years' experience. Confounding factors, such as high‐volume surgeons having a low frequency of complications, have been accounted for in a logistic regression.Conclusion: This study provides insights into cataract surgery practices in Sweden and suggests that surgeons can choose their preferred approach without significantly affecting complication rates. This research also underscores the need for continued exploration of surgical practices and their impact on patient outcomes, particularly in the case of the tilt and tumble technique, which is less commonly employed.


  • Open Access

    Visual Improvement and Lowered Intraocular Pressure After Surgical Management of In-The-Bag Intraocular Lens Dislocation and Aphakia Correction; Retrospective Analysis of Scleral Suturing versus Retropupillary Fixated Iris-Claw Intraocular Lens During a 5-Year Period

    by Bella Johansson Iranipour, Jonas H Rosander, Madeleine Zetterberg

    Purpose: We compare and evaluate the visual outcome and complication rate of two different techniques of surgical management of in-the-bag intraocular lens (IOL) dislocation or aphakia correction. In addition, we evaluate possible risk factors for IOL dislocation or aphakia. Patients and Methods: This retrospective case series reviewed medical records for all patients who had undergone surgery for IOL dislocation or aphakia during a 5-year period at a single ophthalmic center in Sweden. The two most common procedures, scleral suturing of dislocated in-the-bag IOL and retropupillary fixation of iris-claw IOL, were further analyzed. Main outcome measures were best-corrected visual acuity (BCVA), reoperations, and complications. Results: The study comprised 110 eyes, including scleral suturing procedures (n=35) and retropupillary iris-claw IOL (n=75). There was a significantly higher rate of dense cataract (p=0.030) and posterior capsular rupture (PCR), (p=0.016) among iris-claw cases at the primary cataract extraction with pseudoexfoliations in about two-thirds of patients in both groups. All eyes in the scleral suturing group had an IOL dislocation. In the iris-claw group, 23 eyes (30.7%) were aphakic following complicated cataract surgery with PCR. No intraoperative complications occurred in any eyes during the secondary IOL procedure. Both groups showed significant improvement in BCVA, yet there was no significant difference between groups in postoperative BCVA (p=0.263). However, the scleral suturing group experienced a significantly larger improvement in BCVA due to worse BCVA preoperatively (p=0.005). Intraocular pressure decreased significantly after both repositioning and exchange surgery (p=0.002 and 0.010 respectively), but improvement between groups was not significantly different (p=0.264). Conclusion: Both surgical methods resulted in significantly improved BCVA and lowering of IOP and can be considered safe with limited complications. The outcome was similar between groups. Pseudoexfoliation prevalence was high in both groups indicating that it may be a risk factor for either aphakia or late IOL dislocation.